Abbas Dehghan MD PhD FESC is a medical doctor and an epidemiologist. His main research interest is molecular determinants of complex disorders including cardiovascular diseases, type 2 diabetes and dementia. He is a member of the steering committee of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium and has led or been involved in many genome-wide association (GWAS) studies. He has been co-PI of COMBI-BIO, a FP7 EU funded project on metabolomics of atherosclerosis. Dr Dehghan has worked with the Rotterdam Study in the Neterlands for 12 years. He joined the department of epidemiology and biostatistics at Imperial College London since September 2016 as a reader in cardiometabolic disorders. He is working on genetics of omics, in particular metabolimcs, and applying Mendelian Randimisation approach to investigate causal determinants of complex traits and disorders. Since January 2020, Dr Dehghan is also director of post graduet research at the school of public health.
et al., 2020, Long-term prognosis after kidney donation: a propensity score matched comparison of living donors and non-donors from two population cohorts., Eur J Epidemiol
et al., 2020, Could vitamin D reduce obesity-associated inflammation? Observational and Mendelian randomization study, American Journal of Clinical Nutrition, Vol:111, ISSN:0002-9165, Pages:1036-1047
et al., 2020, Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study., Eur Heart J
et al., 2019, GWAS for urinary sodium and potassium excretion highlights pathways shared with cardiovascular traits, Nature Communications, Vol:10, ISSN:2041-1723
et al., 2019, Associations of genetically determined iron status across the phenome: a mendelian randomization study, Plos Medicine, Vol:16, ISSN:1549-1277